Efficient mutation screening for cervical cancers from circulating tumor DNA in blood

Efficient mutation screening for cervical cancers from circulating tumor DNA in blood

Abstract Background Early diagnosis and continuous monitoring are necessary for an efficient management of cervical cancers (CC). Liquid biopsy, such as detecting circulating tumor DNA (ctDNA) from blood, is a simple, non-invasive method for testing and monitoring cancer markers. However, tumor-spec...

Full description

Bibliographic Details
Main Authors: Sun-Young Lee, Dong-Kyu Chae, Sung-Hun Lee, Yohan Lim, Jahyun An, Chang Hoon Chae, Byung Chul Kim, Jong Bhak, Dan Bolser, Dong-Hyu Cho
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Cancer
Subjects:
Cervical cancer
Next-generation-sequencing
Circulating tumor DNA
Cancer panel
Genomic alteration
Online Access:http://link.springer.com/article/10.1186/s12885-020-07161-0

Internet

http://link.springer.com/article/10.1186/s12885-020-07161-0

Similar Items